Skip to content

Trimble

US · TRMB #1216 by market cap Listed 1970
60.06 -0.89 -1.46%
Live - 5344 symbols - heartbeat 367s ago · 2026-10-08 05:34
Pre-market 59.82 -0.40%
After-hours 60.06 0.00%
Overnight 60.06 0.00%
Market cap
14.00B
P/E (TTM)
-125.13
P/B
2.74
EPS
1.76
Reader sentiment Are you bullish or bearish on TRMB?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 2.64 Cheap vs history 15th percentile
5-year average 3.31 · #12 of 32 in Scientific & Technical Instruments
P/E ratio -120.71 Cheap vs history 2nd percentile
5-year average 29.15 · forward 21.37
P/S ratio 3.57 Cheap vs history 27th percentile
5-year average 4.23 · forward 3.32 · #10 of 32 in Scientific & Technical Instruments

Vs. peers Scientific & Technical Instruments

Company Market cap P/E (TTM) P/B Div yield
Trimble (TRMB) 14.00B -125.13 2.74 0.00%
Coherent (COHR) 65.52B 81.20 6.01 0.00%
Keysight Technologies (KEYS) 64.93B 52.39 9.88 0.00%
Garmin (GRMN) 53.26B 28.50 5.90 1.36%
Teledyne Technologies (TDY) 28.01B 29.23 2.56 0.00%
MKS Inc (MKSI) 18.47B 43.50 6.18 0.34%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value71.00 Economic moatNarrow UncertaintyHigh

Trading 18.2% below Morningstar's fair value estimate.

Fair value

Trimble Inc may seem undervalued at first glance, due to its considerable price decline over the past year. However, to account for the risk associated with a potential value trap, we have limited its rating to 3 stars. The stock currently trades at a 20% discount to our quantitative fair value estimate of $71.00 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The company's balance sheet increases our quantitative valuation. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. Reflecting the firm's leverage is its EBITDA/interest coverage ratio of 3.5, which falls in the bottom 30% compared with global peers. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. We believe this is a sign that shares could be undervalued.

On a different note, the company's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to revenue ratio of 3.9, for example, ranks in the top 40% compared with peers globally. This overstates the long-term cash flow growth potential of the organization. Despite our favorable price/fair value ratio, this characteristic is a negative attribute.

Economic moat

The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-10-08 05:34:13 · For reference only, not investment advice and not tailored to your situation.